Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 315, Issue 6, 2018, Pages H1569-H1588

  Stanhewicz, Anna E ^a   Wenner, Megan M ^b   Stachenfeld, Nina S ^c,d  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c JOHN B PIERCE LABORATORY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Androgens; Atherosclerosis; Endothelin; Endothelium; Estradiol; Estrogens; Menopause; Renin angiotensin system

Indexed keywords

ANDROGEN RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; MEDROXYPROGESTERONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

ATHEROSCLEROSIS; BINDING SITE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENZYME RELEASE; HEART PROTECTION; HUMAN; HYPERTENSION; LIFESPAN; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; VASOCONSTRICTION; VASODILATATION; AGING; ANIMAL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEX FACTOR; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; GONADAL HORMONES; HUMANS; SEX FACTORS;

EID: 85059896245     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00396.2018     Document Type: Review

References (255)

1. Adler TE, Usselman CW, Takamata A, Stachenfeld NS. Blood pressure predicts endothelial function and the effects of ethinyl estradiol exposure in young women. Am J Physiol Heart Circ Physiol 315: H925-H933, 2018. doi:10.1152/ajpheart.00188.2018.
2. Ahnstedt H, Cao L, Krause DN, Warfvinge K, Säveland H, Nilsson OG, Edvinsson L. Male-female differences in upregulation of vasoconstrictor responses in human cerebral arteries. PLoS One 8: e62698, 2013. doi:10.1371/journal.pone.0062698.
3. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84: 813-819, 1999. doi:10.1161/01. RES.84.7.813.
4. Allred AJ, Diz DI, Ferrario CM, Chappell MC. Pathways for angio-tensin-(1-7) metabolism in pulmonary and renal tissues. Am J Physiol Renal Physiol 279: F841-F850, 2000. doi:10.1152/ajprenal.2000.279.5. F841.
5. Armstrong SJ, Zhang Y, Stewart KG, Davidge ST. Estrogen replacement reduces PGHS-2-dependent vasoconstriction in the aged rat. Am J Physiol Heart Circ Physiol 283: H893-H898, 2002. doi:10.1152/ajpheart.00148.2002.
6. Baker SE, Limberg JK, Ranadive SM, Joyner MJ. Neurovascular control of blood pressure is influenced by aging, sex, and sex hormones. Am J Physiol Regul Integr Comp Physiol 311: R1271-R1275, 2016. doi:10.1152/ajpregu.00288.2016.
7. Ballard KD, Kupchak BR, Volk BM, Mah E, Shkreta A, Liptak C, Ptolemy AS, Kellogg MS, Bruno RS, Seip RL, Maresh CM, Kraemer WJ, Volek JS. Acute effects of ingestion of a novel whey-derived extract on vascular endothelial function in overweight, middle-aged men and women. Br J Nutr 109: 882-893, 2013. doi:10. 1017/S0007114512002061.
8. Baron S, Manin M, Beaudoin C, Leotoing L, Communal Y, Veyssiere G, Morel L. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem 279: 14579-14586, 2004. doi:10.1074/jbc.M306143200.
9. Barton M. Not lost in translation: emerging clinical importance of the G protein-coupled estrogen receptor GPER. Steroids 111: 37-45, 2016. doi:10.1016/j.steroids.2016.02.016.
10. Basaria S, Harman SM, Travison TG, Hodis H, Tsitouras P, Budoff M, Pencina KM, Vita J, Dzekov C, Mazer NA, Coviello AD, Knapp PE, Hally K, Pinjic E, Yan M, Storer TW, Bhasin S. Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: A randomized clinical trial. JAMA 314: 570-581, 2015. doi:10.1001/jama. 2015.8881.
11. Bernini G, Versari D, Moretti A, Virdis A, Ghiadoni L, Bardini M, Taurino C, Canale D, Taddei S, Salvetti A. Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab 91: 1691-1697, 2006. doi:10.1210/jc. 2005-1398.
12. Bernini GP, Sgro’ M, Moretti A, Argenio GF, Barlascini CO, Cris-tofani R, Salvetti A. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 84: 2008-2012, 1999. doi:10.1210/jcem.84.6.5824.
13. Best PJ, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 128: 285-288, 1998. doi:10. 7326/0003-4819-128-4-199802150-00006.
14. Bilsel AS, Moini H, Tetik E, Aksungar F, Kaynak B, Ozer A. 17Beta-estradiol modulates endothelin-1 expression and release in human endothelial cells. Cardiovasc Res 46: 579-584, 2000. doi:10.1016/S0008-6363(00)00046-8.
15. Blumenthal RS, Heldman AW, Brinker JA, Resar JR, Coombs VJ, Gloth ST, Gerstenblith G, Reis SE. Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. Am J Cardiol 80: 1021-1024, 1997. doi:10.1016/S0002-9149(97)00596-1.
16. Boese AC, Kim SC, Yin KJ, Lee JP, Hamblin MH. Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease. Am J Physiol Heart Circ Physiol 313: H524-H545, 2017. doi:10.1152/ajpheart.00217.2016.
17. Borges CC, Penna-de-Carvalho A, Medeiros Junior JL, Aguila MB, Mandarim-de-Lacerda CA. Ovariectomy modify local renin-angiotensin-aldosterone system gene expressions in the heart of ApoE(‒/‒) mice. Life Sci 191: 1-8, 2017. doi:10.1016/j.lfs.2017.10.002.
18. Bourghardt J, Wilhelmson ASK, Alexanderson C, De Gendt K, Verhoeven G, Krettek A, Ohlsson C, Tivesten A. Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology 151: 5428-5437, 2010. doi:10.1210/en.2010-0663.
19. Bowyer L, Brown MA, Jones M. Vascular reactivity in men and women of reproductive age. Am J Obstet Gynecol 185: 88-96, 2001. doi:10. 1067/mob.2001.114502.
20. Briant LJ, Charkoudian N, Hart EC. Sympathetic regulation of blood pressure in normotension and hypertension: when sex matters. Exp Physiol 101: 219-229, 2016. doi:10.1113/EP085368.
21. Brosnihan KB, Li P, Ganten D, Ferrario CM. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol Regul Integr Comp Physiol 273: R1908-R1915, 1997.
22. Bukowska A, Spiller L, Wolke C, Lendeckel U, Weinert S, Hoffmann J, Bornfleth P, Kutschka I, Gardemann A, Isermann B, Goette A. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp Biol Med (Maywood) 242: 1412-1423, 2017. doi:10.1177/1535370217718808.
23. Buonassisi V, Venter JC. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc Natl Acad Sci USA 73: 1612-1616, 1976. doi:10.1073/pnas.73.5.1612.
24. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85: 2832-2838, 2000. doi:10.1210/jcem.85.8.6740.
25. Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A, Dennerstein L. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84: 4025-4030, 1999. doi:10.1210/jcem.84.11.6158.
26. Calderon-Margalit R, Schwartz SM, Wellons MF, Lewis CE, Daviglus ML, Schreiner PJ, Williams OD, Sternfeld B, Carr JJ, O’Leary DH, Sidney S, Friedlander Y, Siscovick DS. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the “Coronary Artery Risk Development in Young Adults” women’s study. J Clin Endocrinol Metab 95: 4424-4431, 2010. doi:10.1210/jc.2009-2643.
27. Calderon-Margalit R, Siscovick D, Merkin SS, Wang E, Daviglus ML, Schreiner PJ, Sternfeld B, Williams OD, Lewis CE, Azziz R, Schwartz SM, Wellons MF. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women’s study. Arterioscler Thromb Vasc Biol 34: 2688-2694, 2014. doi:10.1161/ATVBAHA.114.304136.
28. Case J, Davison CA. Estrogen alters relative contributions of nitric oxide and cyclooxygenase products to endothelium-dependent vasodilation. J Pharmacol Exp Ther 291: 524-530, 1999.
29. 2+ mobilization. Circ Res 81: 885-892, 1997. doi:10.1161/01.RES.81.5.885.
30. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24: 471-476, 1994. doi:10.1016/0735-1097(94)90305-0.
31. Chen YF, Naftilan AJ, Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19: 456-463, 1992. doi:10.1161/01.HYP.19.5.456.
32. Chinnathambi V, More AS, Hankins GD, Yallampalli C, Sathishku-mar K. Gestational exposure to elevated testosterone levels induces hypertension via heightened vascular angiotensin II type 1 receptor signaling in rats. Biol Reprod 91: 6, 2014. doi:10.1095/biolreprod.114. 118968.
33. Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94: 2614-2619, 1996. doi:10.1161/01.CIR.94.10.2614.
34. Cooke PS, Nanjappa MK, Ko C, Prins GS, Hess RA. Estrogens in male physiology. Physiol Rev 97: 995-1043, 2017. doi:10.1152/physrev. 00018.2016.
35. Costarella CE, Stallone JN, Rutecki GW, Whittier FC. Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther 277: 34-39, 1996.
36. Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Dendrinos S, Augoulea A, Papamichael C, Lambrinoudaki I. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism 61: 193-201, 2012. doi:10.1016/j.metabol. 2011.06.005.
37. Creatsas GC, Malamitsi-Puchner AB, Hassan EA, Economou EB, Aravantinos DI. Endothelin plasma levels in primary amenorrheic adolescents before and after estrogen treatment. J Soc Gynecol Investig 3: 350-353, 1996.
38. Dai W, Ming W, Li Y, Zheng HY, Wei CD, Rui Z, Yan C. Synergistic effect of a physiological ratio of estradiol and testosterone in the treatment of early-stage atherosclerosis. Arch Med Res 46: 619-629, 2015. doi:10.1016/j.arcmed.2015.11.003.
39. Dai-Do D, Espinosa E, Liu G, Rabelink TJ, Julmy F, Yang Z, Mahler F, Lüscher TF. 17Beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. Cardiovasc Res 32: 980-985, 1996.
40. David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, Tostes RC. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 38: 692-696, 2001. doi:10.1161/01.HYP.38.3.692.
41. B receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension. Braz J Med Biol Res 35: 1061-1068, 2002. doi:10.1590/S0100-879X2002000900006.
42. Davidge ST, Zhang Y. Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Circ Res 83: 388-395, 1998. doi:10.1161/01.RES.83.4.388.
43. Davis GC, Gibson KJ, Casley D, Brown MA. Angiotensin II/angio-tensin (1-7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives. J Hypertens 35: 1178-1186, 2017. doi:10.1097/HJH.0000000000001310.
44. Dean SA, Tan J, O’Brien ER, Leenen FH. 17Beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol 288: R759-R766, 2005. doi:10.1152/ajpregu.00595.2004.
45. Debing E, Peeters E, Duquet W, Poppe K, Velkeniers B, Van den Brande P. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy. Eur J Endocrinol 156: 687-693, 2007. doi:10.1530/EJE-06-0702.
46. Deschamps AM, Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol 297: H1806-H1813, 2009. doi:10.1152/ajpheart.00283. 2009.
47. Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 10: e3, 2008. doi:10.1017/S1462399408000598.
48. Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T, Lekakis J, Panidis D. Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest 36: 691-697, 2006. doi:10.1111/j.1365-2362.2006.01712.x.
49. Diamanti-Kandarakis E, Spina G, Kouli C, Migdalis I. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab 86: 4666-4673, 2001. doi:10.1210/jcem.86.10.7904.
50. Dixit KCS, Wu J, Smith LB, Hadoke PWF, Wu FCW. Androgens and coronary artery disease. In: Endotext, edited by De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A. South Dartmouth, MA: MDText.com, 2000.
51. Donato AJ, Gano LB, Eskurza I, Silver AE, Gates PE, Jablonski K, Seals DR. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 297: H425-H432, 2009. doi:10.1152/ajpheart.00689.2008.
52. Dowman JK, Hopkins LJ, Reynolds GM, Armstrong MJ, Nasiri M, Nikolaou N, van Houten EL, Visser JA, Morgan SA, Lavery GG, Oprescu A, Hübscher SG, Newsome PN, Tomlinson JW. Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice. Endocrinology 154: 4536-4547, 2013. doi:10.1210/en.2013-1592.
53. Ellison KE, Ingelfinger JR, Pivor M, Dzau VJ. Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest 83: 1941-1945, 1989. doi:10.1172/JCI114102.
54. Elmarakby AA, Katary M, Pollock JS, Sullivan JC. Influence of the selective COX-2 inhibitor celecoxib on sex differences in blood pressure and albuminuria in spontaneously hypertensive rats. Prostaglandins Other Lipid Mediat 135: 16-20, 2018. doi:10.1016/j.prostaglandins. 2018.02.002.
55. Endlich PW, Claudio ER, Lima LC, Ribeiro Júnior RF, Peluso AA, Stefanon I, Bissoli NS, Lemos VS, Santos RA, Abreu GR. Exercise modulates the aortic renin-angiotensin system independently of estrogen therapy in ovariectomized hypertensive rats. Peptides 87: 41-49, 2017. doi:10.1016/j.peptides.2016.11.010.
56. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 21: 890-894, 2000. doi:10.1053/euhj.1999.1873.
57. Ergul A, Shoemaker K, Puett D, Tackett RL. Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. J Pharmacol Exp Ther 285: 511-517, 1998.
58. Fagman JB, Wilhelmson AS, Motta BM, Pirazzi C, Alexanderson C, De Gendt K, Verhoeven G, Holmäng A, Anesten F, Jansson J-O, Levin M, Borén J, Ohlsson C, Krettek A, Romeo S, Tivesten Å. The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice. FASEB J 29: 1540-1550, 2015. doi:10.1096/fj.14-259234.
59. Ferrer M, Meyer M, Osol G. Estrogen replacement increases beta-adrenoceptor-mediated relaxation of rat mesenteric arteries. J Vasc Res 33: 124-131, 1996. doi:10.1159/000159140.
60. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14: 1649-1660, 2000. doi:10.1210/mend.14.10.0532.
61. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53: 672-677, 2002. doi:10.1016/S0008-6363(01)00479-5.
62. Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol 29: 169-181, 2008. doi:10.1016/j.yfrne. 2007.10.005.
63. Fredette NC, Meyer MR, Prossnitz ER. Role of GPER in estrogen-dependent nitric oxide formation and vasodilation. J Steroid Biochem Mol Biol 176: 65-72, 2018. doi:10.1016/j.jsbmb.2017.05.006.
64. Freshour JR, Chase SE, Vikstrom KL. Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice. Am J Physiol Heart Circ Physiol 283: H1997-H2003, 2002. doi:10.1152/ajpheart.01054.2001.
65. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33: 323-328, 1999. doi:10.1161/01.HYP.33.1.323.
66. Gandhi SK, Gainer J, King D, Brown NJ. Gender affects renal vasoconstrictor response to Ang I and Ang II. Hypertension 31: 90-96, 1998. doi:10.1161/01.HYP.31.1.90.
67. Gavin KM, Seals DR, Silver AE, Moreau KL. Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab 94: 3513-3520, 2009. doi:10.1210/jc. 2009-0278.
68. Gohar EY, Giachini FR, Pollock DM, Tostes RC. Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases. Life Sci 159: 20-29, 2016. doi:10.1016/j.lfs.2016.02.093.
69. Grohé C, Kahlert S, Löbbert K, Vetter H. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J Endocrinol 156: R1-R7, 1998. doi:10.1677/joe.0.156R001.
70. Gupte M, Thatcher SE, Boustany-Kari CM, Shoemaker R, Yian-nikouris F, Zhang X, Karounos M, Cassis LA. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol 32: 1392-1399, 2012. doi:10.1161/ATVBAHA.112.248559.
71. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, Heigl A, Lachat M, Genoni M, Barton M. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49: 1358-1363, 2007. doi:10.1161/HYPERTENSIONAHA.107.089995.
72. Haffner SM, Newcomb PA, Marcus PM, Klein BE, Klein R. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 142: 925-934, 1995. doi:10.1093/oxfordjournals.aje.a117740.
73. Hak AE, Westendorp IC, Pols HA, Hofman A, Witteman JC. High-dose testosterone is associated with atherosclerosis in postmenopausal women. Maturitas 56: 153-160, 2007. doi:10.1016/j.maturitas.2006.07. 004.
74. Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y. Localized expression of aromatase in human vascular tissues. Circ Res 84: 1285-1291, 1999. doi:10.1161/01.RES.84.11.1285.
75. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ; STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 97: 1159-1168, 2012. doi:10.1210/jc.2011-3362.
76. Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach J, Joyner MJ. Sex and ageing differences in resting arterial pressure regulation: the role of the β-adrenergic receptors. J Physiol 589: 5285-5297, 2011. doi:10.1113/jphysiol.2011.212753.
77. Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach JH, Joyner MJ. Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation. Hypertension 53: 571-576, 2009. doi:10.1161/HYPERTENSIONAHA.108.126391.
78. Hart EC, Joyner MJ, Wallin BG, Charkoudian N. Sex, ageing and resting blood pressure: gaining insights from the integrated balance of neural and haemodynamic factors. J Physiol 590: 2069-2079, 2012. doi:10.1113/jphysiol.2011.224642.
79. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, Sagara Y, Taketani Y, Orimo H, Ouchi Y. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 92: 3431-3435, 1995. doi:10.1161/01.CIR. 92.12.3431.
80. Hassager C, Riis BJ, Strøm V, Guyene TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 76: 753-758, 1987. doi:10. 1161/01.CIR.76.4.753.
81. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engage-engage-ment activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87: 677-682, 2000. doi:10.1161/01.RES.87.8.677. ment
82. Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16: 2181-2187, 2002. doi:10.1210/me.2002-0070.
83. Hilliard LM, Mirabito KM, Denton KM. Unmasking the potential of the angiotensin AT2 receptor as a therapeutic target in hypertension in men and women: what we know and what we still need to find out. Clin Exp Pharmacol Physiol 40: 542-550, 2013. doi:10.1111/1440-1681. 12067.
84. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 360: 291-293, 1995. doi:10.1016/0014-5793(95)00124-R.
85. Hogg ME, Vavra AK, Banerjee MN, Martinez J, Jiang Q, Keefer LK, Chambon P, Kibbe MR. The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sex. J Surg Res 173: e1-e10, 2012. doi:10.1016/j.jss.2011.09.021.
86. Holmboe SA, Vradi E, Jensen TK, Linneberg A, Husemoen LLN, Scheike T, Skakkebæk NE, Juul A, Andersson A-M. The association of reproductive hormone levels and all-cause, cancer, and cardiovascular disease mortality in men. J Clin Endocrinol Metab 100: 4472-4480, 2015. doi:10.1210/jc.2015-2460.
87. Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG, Cheng TH. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 61: 159-168, 2004. doi:10.1016/j.cardiores.2003.10.019.
88. Huang CK, Lee SO, Chang E, Pang H, Chang C. Androgen receptor (AR) in cardiovascular diseases. J Endocrinol 229: R1-R16, 2016. doi:10.1530/JOE-15-0518.
89. Hudson M, Rahme E, Behlouli H, Sheppard R, Pilote L. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart fail-ure—a population study. Eur J Heart Fail 9: 602-609, 2007. doi:10. 1016/j.ejheart.2007.02.001.
90. Hurtado R, Celani M, Geber S. Effect of short-term estrogen therapy on endothelial function: a double-blinded, randomized, controlled trial. Climacteric 19: 448-451, 2016. doi:10.1080/13697137.2016.1201809.
91. Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW, Chatterjee K. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. JAm Coll Cardiol 29: 800-807, 1997. doi:10.1016/S0735-1097(96)00570-0.
92. Ihionkhan CE, Chambliss KL, Gibson LL, Hahner LD, Mendelsohn ME, Shaul PW. Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res 91: 814-820, 2002. doi:10.1161/01.RES.0000038304.62046.4C.
93. Intapad S, Ojeda NB, Varney E, Royals TP, Alexander BT. Sex-specific effect of endothelin in the blood pressure response to acute angiotensin II in growth-restricted rats. Hypertension 66: 1260-1266, 2015. doi:10.1161/HYPERTENSIONAHA.115.06257.
94. Jazbutyte V, Stumpner J, Redel A, Lorenzen JM, Roewer N, Thum T, Kehl F. Aromatase inhibition attenuates desflurane-induced preconditioning against acute myocardial infarction in male mouse heart in vivo. PLoS One 7: e42032, 2012. doi:10.1371/journal.pone.0042032.
95. Jesmin S, Mowa CN, Sultana SN, Shimojo N, Togashi H, Iwashima Y, Kato N, Sato A, Sakuma I, Hiroe M, Hattori Y, Yamaguchi N, Kobayashi H. VEGF signaling is disrupted in the hearts of mice lacking estrogen receptor alpha. Eur J Pharmacol 641: 168-178, 2010. doi:10. 1016/j.ejphar.2010.05.020.
96. Jones RD, Pugh PJ, Jones TH, Channer KS. The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br J Pharmacol 138: 733-744, 2003. doi:10.1038/sj.bjp. 0705141.
97. Juan SH, Chen JJ, Chen CH, Lin H, Cheng CF, Liu JC, Hsieh MH, Chen YL, Chao HH, Chen TH, Chan P, Cheng TH. 17β-Estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am J Physiol Heart Circ Physiol 287: H1254-H1261, 2004. doi:10.1152/ajpheart.00723.2003.
98. Kang LS, Chen B, Reyes RA, Leblanc AJ, Teng B, Mustafa SJ, Muller-Delp JM. Aging and estrogen alter endothelial reactivity to reactive oxygen species in coronary arterioles. Am J Physiol Heart Circ Physiol 300: H2105-H2115, 2011. doi:10.1152/ajpheart.00349.2010.
99. Kauser K, Rubanyi GM. Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. J Vasc Res 34: 229-236, 1997. doi:10.1159/000159227.
100. B receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension. Clin Exp Pharmacol Physiol 34: 280-285, 2007. doi:10.1111/j.1440-1681.2007.04580.x.
101. Kellogg DL Jr, Liu Y, Pérgola PE. Selected contribution: gender differences in the endothelin-B receptor contribution to basal cutaneous vascular tone in humans. J Appl Physiol 91: 2407-2411, 2001. doi:10. 1152/jappl.2001.91.5.2407.
102. Kim KH, Bender JR. Rapid, estrogen receptor-mediated signaling: why is the endothelium so special? Sci STKE 2005: pe28, 2005. doi:10.1126/stke.2882005pe28.
103. Kim SC, Boese AC, Moore MH, Cleland RM, Chang L, Delafontaine P, Yin KJ, Lee JP, Hamblin MH. Rapid estrogen receptor-α signaling mediated by ERK activation regulates vascular tone in male and ovary-intact female mice. Am J Physiol Heart Circ Physiol 314: H330-H342, 2018. doi:10.1152/ajpheart.00841.2016.
104. Kimura M, Sudhir K, Jones M, Simpson E, Jefferis A-M, Chin-Dusting JPF. Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males. Circ Res 93: 1267-1271, 2003. doi:10.1161/01.RES.0000103172.98986.25.
105. Kiprono LV, Wallace K, Moseley J, Martin J Jr, Lamarca B. Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia. Am J Obstet Gynecol 209: 44.e1-44.e6, 2013. doi:10.1016/j.ajog.2013.03.032.
106. Kische H, Gross S, Wallaschofski H, Völzke H, Dörr M, Nauck M, Felix SB, Haring R. Serum androgen concentrations and subclinical measures of cardiovascular disease in men and women. Atherosclerosis 247: 193-200, 2016. doi:10.1016/j.atherosclerosis.2016.02.020.
107. B receptors contribute to sex differences in blood pressure elevation in angiotensin II hypertensive rats on a high-salt diet. Clin Exp Pharmacol Physiol 40: 362-370, 2013. doi:10.1111/1440-1681.12084.
108. Kittikulsuth W, Pollock JS, Pollock DM. Loss of renal medullary endothelin B receptor function during salt deprivation is regulated by angiotensin II. Am J Physiol Renal Physiol 303: F659-F666, 2012. doi:10.1152/ajprenal.00213.2012.
109. Kittikulsuth W, Sullivan JC, Pollock DM. ET-1 actions in the kidney: evidence for sex differences. Br J Pharmacol 168: 318-326, 2013. doi:10.1111/j.1476-5381.2012.01922.x.
110. Kobori H, Urushihara M, Xu JH, Berenson GS, Navar LG. Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens 28: 1422-1428, 2010. doi:10.1097/HJH. 0b013e3283392673.
111. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V; Bosentan Hypertension Investigators. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N Engl J Med 338: 784-791, 1998. doi:10. 1056/NEJM199803193381202.
112. Kumanov P, Tomova A, Kirilov G. Testosterone replacement therapy in male hypogonadism is not associated with increase of endothelin-1 levels. Int J Androl 30: 41-47, 2007. doi:10.1111/j.1365-2605.2006. 00706.x.
113. Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Arge-itis J, Vlachou S, Creatsa M, Kouskouni E, Botsis D. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol 154: 907-916, 2006. doi:10.1530/eje. 1.02167.
114. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93: 68-75, 2008. doi:10.1210/jc.2007-1792.
115. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Mühlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85: 645-651, 2000. doi:10.1210/jcem.85.2.6405.
116. LeBlanc AJ, Reyes R, Kang LS, Dailey RA, Stallone JN, Moningka NC, Muller-Delp JM. Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 297: R1713-R1723, 2009. doi:10. 1152/ajpregu.00178.2009.
117. Lew R, Komesaroff P, Williams M, Dawood T, Sudhir K. Endogenous estrogens influence endothelial function in young men. Circ Res 93: 1127-1133, 2003. doi:10.1161/01.RES.0000103633.57225.BC.
118. Li L, Hisamoto K, Kim KH, Haynes MP, Bauer PM, Sanjay A, Collinge M, Baron R, Sessa WC, Bender JR. Variant estrogen recep-tor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc Natl Acad Sci USA 104: 16468-16473, 2007. doi:10.1073/pnas.0704315104.
119. Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep 14: 254-260, 2012. doi:10.1007/s11906-012-0260-0.
120. Lima R, Yanes LL, Davis DD, Reckelhoff JF. Roles played by 20-HETE, angiotensin II, and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 304: R248-R251, 2013. doi:10.1152/ajpregu.00380.2012.
121. Lin YJ, Kwok CF, Juan CC, Hsu YP, Shih KC, Chen CC, Ho LT. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor. Biochem Biophys Res Commun 451: 263-269, 2014. doi:10.1016/j.bbrc.2014.07.119.
122. Liu PY, Christian RC, Ruan M, Miller VM, Fitzpatrick LA. Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. J Clin Endocrinol Metab 90: 1041-1046, 2005. doi:10.1210/jc. 2004-1211.
123. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 24: 313-340, 2003. doi:10.1210/er.2003-0005.
124. Lopes RAM, Neves KB, Pestana CR, Queiroz AL, Zanotto CZ, Chignalia AZ, Valim YM, Silveira LR, Curti C, Tostes RC. Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvement. Am J Physiol Heart Circ Physiol 306: H1485-H1494, 2014. doi:10.1152/ajpheart.00809.2013.
125. Luo C, Pook E, Tang B, Zhang W, Li S, Leineweber K, Cheung SH, Chen Q, Bechem M, Hu JS, Laux V, Wang QK. Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription. Biochim Biophys Acta Mol Basis Dis 1863: 2319-2332, 2017. doi:10. 1016/j.bbadis.2017.06.015.
126. Lygnos MC, Pappa KI, Papadaki HA, Relakis C, Koumantakis E, Anagnou NP, Eliopoulos GD. Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo 20: 157-163, 2006.
127. MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS, Shaul PW. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 81: 355-362, 1997. doi:10.1161/01.RES.81.3.355.
128. Maeda S, Tanabe T, Miyauchi T, Otsuki T, Sugawara J, Iemitsu M, Kuno S, Ajisaka R, Yamaguchi I, Matsuda M. Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J Appl Physiol 95: 336-341, 2003. doi:10.1152/japplphysiol.01016.2002.
129. Malik RA, Schofield IJ, Izzard A, Austin C, Bermann G, Heagerty AM. Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus. Hypertension 45: 264-269, 2005. doi:10.1161/01.HYP.0000153305.50128.a1.
130. Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, Nippoldt TB, Prokop LJ, Murad MH. Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab 102: 3914-3923, 2017. doi:10. 1210/jc.2017-01643.
131. Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 57: 961-965, 2008. doi:10.1016/j. metabol.2008.02.012.
132. Mazzuca MQ, Khalil RA. Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol 84: 147-162, 2012. doi:10.1016/j.bcp.2012.03.020.
133. McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 99: 2317-2322, 1999. doi:10.1161/01.CIR.99.17.2317.
134. McNeill AM, Kim N, Duckles SP, Krause DN. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30: 2186-2190, 1999. doi:10.1161/01. STR.30.10.2186.
135. Meendering JR, Torgrimson BN, Miller NP, Kaplan PF, Minson CT. Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women. Am J Physiol Heart Circ Physiol 294: H1630-H1637, 2008. doi:10.1152/ajpheart.01314.2007.
136. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999. doi:10. 1056/NEJM199906103402306.
137. Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 11: 509-517, 2008. doi:10.1080/13697130802416640.
138. Meyer MR, Amann K, Field AS, Hu C, Hathaway HJ, Kanagy NL, Walker MK, Barton M, Prossnitz ER. Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension 59: 507-512, 2012. doi:10.1161/HYPERTENSIONAHA.111.184606.
139. Meyer MR, Haas E, Prossnitz ER, Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol 308: 9-16, 2009. doi:10.1016/j.mce.2009.03.009.
140. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 60: 210-241, 2008. doi:10.1124/pr.107. 08002.
141. Miller VM, Mulvagh SL. Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci 28: 263-270, 2007. doi:10.1016/j.tips.2007.04.004.
142. Mineo C, Shaul PW. Regulation of eNOS in caveolae. In: Caveolins and Caveolae: Roles in Signaling and Disease Mechanisms, edited by Jasmin JF, Frank PG, Lisanti MP. New York: Springer, 2012, p. 51-62. doi:10. 1007/978-1-4614-1222-9_4.
143. Miner JA, Martini ER, Smith MM, Brunt VE, Kaplan PF, Halliwill JR, Minson CT. Short-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women. Am J Physiol Heart Circ Physiol 301: H1716-H1722, 2011. doi:10.1152/ajpheart.00405.2011.
144. Miner M, Canty DJ, Shabsigh R. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices. Postgrad Med 120: 130-153, 2008. doi:10.3810/pgm.2008.09.1914.
145. Mishra JS, Hankins GD, Kumar S. Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta. J Renin Angiotensin Aldosterone Syst 17: 17, 2016. doi:10.1177/1470320316674875.
146. Molinari C, Battaglia A, Grossini E, Mary DA, Surico N, Vacca G. Effect of progesterone on peripheral blood flow in prepubertal female anesthetized pigs. J Vasc Res 38: 569-577, 2001. doi:10.1159/000051093.
147. Mompeón A, Lázaro-Franco M, Bueno-Betí C, Pérez-Cremades D, Vidal-Gómez X, Monsalve E, Gironacci MM, Hermenegildo C, Novella S. Estradiol, acting through ERα, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1-7 production. Mol Cell Endocrinol 422: 1-8, 2016. doi:10.1016/j.mce.2015.11.004.
148. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Endogenous testosterone and endothelial function in postmenopausal women. Coron Artery Dis 18: 9-13, 2007. doi:10.1097/01. mca.0000236290.79306.d1.
149. Moreau KL, DePaulis AR, Gavin KM, Seals DR. Oxidative stress contributes to chronic leg vasoconstriction in estrogen-deficient postmenopausal women. J Appl Physiol 102: 890-895, 2007. doi:10.1152/japplphysiol.00877.2006.
150. Moreau KL, Hildreth KL, Meditz AL, Deane KD, Kohrt WM. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab 97: 4692-4700, 2012. doi:10.1210/jc.2012-2244.
151. Moreau KL, Stauffer BL, Kohrt WM, Seals DR. Essential role of estrogen for improvements in vascular endothelial function with endurance exercise in postmenopausal women. J Clin Endocrinol Metab 98: 4507-4515, 2013. doi:10.1210/jc.2013-2183.
152. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH; atherosclerosis risk in communities study. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab 90: 1202-1209, 2005. doi:10.1210/jc.2004-0744.
153. Mügge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17 β-oestradiol in vitro. Cardiovasc Res 27: 1939-1942, 1993. doi:10.1093/cvr/27.11. 1939.
154. Nakagawa K, Marji JS, Schwartzman ML, Waterman MR, Capdev-ila JH. Androgen-mediated induction of the kidney arachidonate hy-droxylases is associated with the development of hypertension. Am J Physiol Regul Integr Comp Physiol 284: R1055-R1062, 2003. doi:10. 1152/ajpregu.00459.2002.
155. Nakov R, Pfarr E, Eberle S; HEAT Investigators. Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension. Am J Hypertens 15: 583-589, 2002. doi:10.1016/S0895-7061(02)02933-3.
156. Nettleship JE, Jones TH, Channer KS, Jones RD. Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor. Circulation 116: 2427-2434, 2007. doi:10.1161/CIRCULATIONAHA.107.708768.
157. Nicholson WT, Vaa B, Hesse C, Eisenach JH, Joyner MJ. Aging is associated with reduced prostacyclin-mediated dilation in the human forearm. Hypertension 53: 973-978, 2009. doi:10.1161/HYPERTENSIONAHA. 108.121483.
158. 1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-2201, 1998. doi:10.1161/01.CIR.97.22. 2197.
159. 1 receptor gene expression in vascular smooth muscle cells. Circulation 102: 1828-1833, 2000. doi:10.1161/01.CIR.102.15.1828.
160. Nogawa N, Sumino H, Ichikawa S, Kumakura H, Takayama Y, Nakamura T, Kanda T, Mizunuma H, Kurabayashi M. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women. Menopause 8: 210-215, 2001. doi:10.1097/00042192-200105000-00011.
161. Nyberg M, Egelund J, Mandrup CM, Nielsen MB, Mogensen AS, Stallknecht B, Bangsbo J, Hellsten Y. Early postmenopausal phase is associated with reduced prostacyclin-induced vasodilation that is reversed by exercise training: the Copenhagen Women Study. Hypertension 68: 1011-1020, 2016. doi:10.1161/HYPERTENSIONAHA.116. 07866.
162. Ojeda NB, Royals TP, Alexander BT. Sex differences in the enhanced responsiveness to acute angiotensin II in growth-restricted rats: role of fasudil, a Rho kinase inhibitor. Am J Physiol Renal Physiol 304: F900-F907, 2013. doi:10.1152/ajprenal.00687.2012.
163. Ojeda NB, Royals TP, Black JT, Dasinger JH, Johnson JM, Alexander BT. Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspring. Am J Physiol Regul Integr Comp Physiol 298: R1421-R1427, 2010. doi:10.1152/ajpregu. 00096.2010.
164. Okano H, Jayachandran M, Yoshikawa A, Miller VM. Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells. J Cardiovasc Pharmacol 47: 621-628, 2006. doi:10.1097/01.fjc. 0000211749.24196.98.
165. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286: R233-R249, 2004. doi:10.1152/ajpregu.00338.2003.
166. Ouyang P, Vaidya D, Dobs A, Golden SH, Szklo M, Heckbert SR, Kopp P, Gapstur SM. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 204: 255-261, 2009. doi:10.1016/j.atherosclerosis. 2008.08.037.
167. 1) receptor expression by PET. J Nucl Med 45: 94-100, 2004.
168. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103: 1410-1415, 2001. doi:10.1161/01. CIR.103.10.1410.
169. Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, Cauley JA, Sutton-Tyrrell K, Robbins J, Fried LP, Cappola AR. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 94: 4776-4784, 2009. doi:10.1210/jc. 2009-0740.
170. Pearson LJ, Yandle TG, Nicholls MG, Evans JJ. Regulation of endothelin-1 release from human endothelial cells by sex steroids and angiotensin-II. Peptides 29: 1057-1061, 2008. doi:10.1016/j.peptides. 2008.02.003.
171. Pedersen SH, Nielsen LB, Mortensen A, Nilas L, Ottesen B. Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits. Menopause 15: 503-510, 2008. doi:10.1097/gme.0b013e318156f803.
172. Peiró C, Vallejo S, Gembardt F, Azcutia V, Heringer-Walther S, Rodríguez-Mañas L, Schultheiss HP, Sánchez-Ferrer CF, Walther T. Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. J Hypertens 25: 2421-2425, 2007. doi:10.1097/HJH. 0b013e3282f0143c.
173. Phillips GB. Is atherosclerotic cardiovascular disease an endocrinolog-ical disorder? The estrogen-androgen paradox. J Clin Endocrinol Metab 90: 2708-2711, 2005. doi:10.1210/jc.2004-2011.
174. Phillips GB, Pinkernell BH, Jing TY. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 17: 695-701, 1997. doi:10.1161/01.ATV.17. 4.695.
175. Pierce GL, Donato AJ, LaRocca TJ, Eskurza I, Silver AE, Seals DR. Habitually exercising older men do not demonstrate age-associated vascular endothelial oxidative stress. Aging Cell 10: 1032-1037, 2011. doi:10.1111/j.1474-9726.2011.00748.x.
176. Pihlajamaa P, Sahu B, Jänne OA. Determinants of receptor-and tissue-specific actions in androgen signaling. Endocr Rev 36: 357-384, 2015. doi:10.1210/er.2015-1034.
177. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Ver-heugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118: 429-432, 1993. doi:10.7326/0003-4819-118-6-199303150-00006.
178. Prossnitz ER, Arterburn JB, Sklar LA. GPR30: a G protein-coupled receptor for estrogen. Mol Cell Endocrinol 265-266: 138-142, 2007. doi:10.1016/j.mce.2006.12.010.
179. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 43: 918-923, 2004. doi:10. 1161/01.HYP.0000124670.03674.15.
180. Reckelhoff JF, Roman RJ. Androgens and hypertension: role in both males and females? Hypertension 57: 681-682, 2011. doi:10.1161/HYPERTENSIONAHA.110.162750.
181. Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31: 435-439, 1998. doi:10.1161/01.HYP.31.1. 435.
182. Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34: 920-923, 1999. doi:10. 1161/01.HYP.34.4.920.
183. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630, 2005. doi:10.1126/science.1106943.
184. Reynolds SR, Foster FI. Peripheral vascular action of estrogen in the human male. J Clin Invest 18: 649-655, 1939. doi:10.1172/JCI101080.
185. Rodrigo MC, Martin DS, Eyster KM. Vascular ECE-1 mRNA expression decreases in response to estrogens. Life Sci 73: 2973-2983, 2003. doi:10.1016/j.lfs.2003.05.001.
186. Roesch DM, Tian Y, Zheng W, Shi M, Verbalis JG, Sandberg K. Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats. Endocrinology 141: 4629-4636, 2000. doi:10.1210/endo. 141.12.7822.
187. Rosano GM, Sheiban I, Massaro R, Pagnotta P, Marazzi G, Vitale C, Mercuro G, Volterrani M, Aversa A, Fini M. Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res 19: 176-182, 2007. doi:10.1038/sj.ijir.3901504.
188. Rosenthal T, Oparil S. Hypertension in women. J Hum Hypertens 14: 691-704, 2000. doi:10.1038/sj.jhh.1001095.
189. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97: 5930-5935, 2000. doi:10.1073/pnas.97.11.5930.
190. Safari T, Nematbakhsh M, Hilliard LM, Evans RG, Denton KM. Sex differences in the renal vascular response to angiotensin II involves the Mas receptor. Acta Physiol (Oxf) 206: 150-156, 2012. doi:10.1111/j. 1748-1716.2012.02468.x.
191. Salazar M, Lerma-Ortiz A, Hooks GM, Ashley AK, Ashley RL. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors. Gene 591: 6-13, 2016. doi:10.1016/j.gene.2016. 06.044.
192. Sampson AK, Hilliard LM, Moritz KM, Thomas MC, Tikellis C, Widdop RE, Denton KM. The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent. Am J Physiol Regul Integr Comp Physiol 302: R159-R165, 2012. doi:10. 1152/ajpregu.00256.2011.
193. Sampson AK, Moritz KM, Denton KM. Postnatal ontogeny of angiotensin receptors and ACE2 in male and female rats. Gend Med 9: 21-32, 2012. doi:10.1016/j.genm.2011.12.003.
194. Sampson AK, Moritz KM, Jones ES, Flower RL, Widdop RE, Denton KM. Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension 52: 666-671, 2008. doi:10. 1161/HYPERTENSIONAHA.108.114058.
195. Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 81: 1495-1501, 1996.
196. Scaling AL, Prossnitz ER, Hathaway HJ. GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast. Horm Cancer 5: 146-160, 2014. doi:10. 1007/s12672-014-0174-1.
197. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101: 1653-1659, 2000. doi:10.1161/01.CIR.101.14.1653.
198. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 287: H435-H446, 2004. doi:10.1152/ajpheart.00262.2004.
199. Schneider MP, Wach PF, Durley MK, Pollock JS, Pollock DM. Sex differences in acute ANG II-mediated hemodynamic responses in mice. Am J Physiol Regul Integr Comp Physiol 299: R899-R906, 2010. doi:10.1152/ajpregu.00638.2009.
200. Schunkert H, Danser AH, Hense HW, Derkx FH, Kürzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 95: 39-45, 1997. doi:10.1161/01.CIR.95.1.39.
201. Sebzda KN, Kuczmarski AV, Pohlig RT, Lennon SL, Edwards DG, Wenner MM. Ovarian hormones modulate endothelin-1 receptor responses in young women. Microcirculation 25: e12490, 2018. doi:10. 1111/micc.12490.
202. Selles J, Polini N, Alvarez C, Massheimer V. Progesterone and 17 beta-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation. Life Sci 69: 815-827, 2001. doi:10.1016/S0024-3205(01)01174-2.
203. Sharma G, Prossnitz ER. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic β-cells. Endocrinology 152: 3030-3039, 2011. doi:10.1210/en.2011-0091.
204. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 72: 2115-2124, 1983. doi:10.1172/JCI111176.
205. Simões e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 169: 477-492, 2013. doi:10.1111/bph.12159.
206. Simoncini T, Mannella P, Fornari L, Caruso A, Willis MY, Garibaldi S, Baldacci C, Genazzani AR. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 145: 5745-5756, 2004. doi:10.1210/en.2004-0510.
207. Singh H, Cheng J, Deng H, Kemp R, Ishizuka T, Nasjletti A, Schwartzman ML. Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension. Hypertension 50: 123-129, 2007. doi:10.1161/HYPERTENSIONAHA.107.089599.
208. Sobrino A, Vallejo S, Novella S, Lázaro-Franco M, Mompeón A, Bueno-Betí C, Walther T, Sánchez-Ferrer C, Peiró C, Hermenegildo C. Mas receptor is involved in the estrogen-receptor induced nitric oxide-dependent vasorelaxation. Biochem Pharmacol 129: 67-72, 2017. doi:10.1016/j.bcp.2017.01.012.
209. Sokolnicki LA, Khosla S, Charkoudian N. Effects of testosterone and estradiol on cutaneous vasodilation during local warming in older men. Am J Physiol Endocrinol Metab 293: E1426-E1429, 2007. doi:10.1152/ajpendo.00535.2007.
210. Somjen D, Kohen F, Gayer B, Sharon O, Baz M, Limor R, Kulik T, Knoll E, Stern N. Role of putative membrane receptors in the effects of estradiol on human vascular cell growth. Am J Hypertens 17: 462-469, 2004. doi:10.1016/j.amjhyper.2004.01.002.
211. Song J, Kost CK Jr, Martin DS. Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway. Cardiovasc Res 72: 456-463, 2006. doi:10.1016/j.cardiores. 2006.09.007.
212. Stauffer BL, Westby CM, Greiner JJ, Van Guilder GP, Desouza CA. Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults. Am J Physiol Regul Integr Comp Physiol 298: R261-R265, 2010. doi:10.1152/ajpregu.00626.2009.
213. Streed CG Jr, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee M. Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review. Ann Intern Med 167: 256-267, 2017. doi:10.7326/M17-0577.
214. Studen KB, Šebeštjen M, Pfeifer M, Preželj J. Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome. Eur J Endocrinol 164: 389-395, 2011. doi:10.1530/EJE-10-0709.
215. Sudhir K, Ko E, Zellner C, Wong HE, Hutchison SJ, Chou TM, Chatterjee K. Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. Circulation 96: 3626-3632, 1997. doi:10.1161/01.CIR.96.10.3626.
216. Sullivan JC. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol 294: R1220-R1226, 2008. doi:10.1152/ajpregu.00864.2007.
217. Sullivan JC, Bhatia K, Yamamoto T, Elmarakby AA. Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats. Hypertension 56: 658-666, 2010. doi:10.1161/HYPERTENSIONAHA.110.153668.
218. Sullivan JC, Rodriguez-Miguelez P, Zimmerman MA, Harris RA. Differences in angiotensin (1-7) between men and women. Am J Physiol Heart Circ Physiol 308: H1171-H1176, 2015. doi:10.1152/ajpheart. 00897.2014.
219. Sullivan JC, Sasser JM, Pollock DM, Pollock JS. Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension 45: 406-411, 2005. doi:10.1161/01.HYP.0000156879. 83448.93.
220. Tan Z, Wang TH, Chen Y, Lin GP, Pan JY. [Role of NO signal pathway in the inhibitory of 17beta-estradiol on the production of endothelin-1 in vascular smooth muscle cells]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 23: 347-350, 2007.
221. Tan Z, Wang TH, Yang D, Fu XD, Pan JY. Mechanisms of 17beta-estradiol on the production of ET-1 in ovariectomized rats. Life Sci 73: 2665-2674, 2003. doi:10.1016/S0024-3205(03)00605-2.
222. Tanaka M, Nakaya S, Watanabe M, Kumai T, Tateishi T, Kobayashi S. Effects of ovariectomy and estrogen replacement on aorta angiotensin-converting enzyme activity in rats. Jpn J Pharmacol 73: 361-363, 1997. doi:10.1254/jjp.73.361.
223. Teoh H, Quan A, Leung SW, Man RY. Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries. Br J Pharmacol 129: 1301-1308, 2000. doi:10.1038/sj.bjp. 0703164.
224. Thomas P, Pang Y. Protective actions of progesterone in the cardiovascular system: potential role of membrane progesterone receptors (mPRs) in mediating rapid effects. Steroids 78: 583-588, 2013. doi:10.1016/j. steroids.2013.01.003.
225. Toering TJ, van der Graaf AM, Visser FW, Buikema H, Navis G, Faas MM, Lely AT. Gender differences in response to acute and chronic angiotensin II infusion: a translational approach. Physiol Rep 3: e12434, 2015. doi:10.14814/phy2.12434.
226. Torres-Estay V, Carreño DV, San Francisco IF, Sotomayor P, Godoy AS, Smith GJ. Androgen receptor in human endothelial cells. J Endocrinol 224: R131-R137, 2015. doi:10.1530/JOE-14-0611.
227. B receptor-mediated vascular responses. Br J Pharmacol 130: 1092-1098, 2000. doi:10.1038/sj.bjp. 0703389.
228. Tostes RC, Fortes ZB, Callera GE, Montezano AC, Touyz RM, Webb RC, Carvalho MH. Endothelin, sex and hypertension. Clin Sci (Lond) 114: 85-97, 2008. doi:10.1042/CS20070169.
229. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19: 1245-1254, 2001. doi:10.1097/00004872-200107000-00009.
230. Usselman CW, Stachenfeld NS, Bender JR. The molecular actions of oestrogen in the regulation of vascular health. Exp Physiol 101: 356-361, 2016. doi:10.1113/EP085148.
231. Valdés G, Germain AM, Corthorn J, Berrios C, Foradori AC, Ferrario CM, Brosnihan KB. Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine 16: 117-122, 2001. doi:10.1385/ENDO:16:2:117.
232. Van Guilder GP, Westby CM, Greiner JJ, Stauffer BL, DeSouza CA. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 50: 403-409, 2007. doi:10.1161/HYPERTENSIONAHA.107.088294.
233. Vigen R, O’Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310: 1829-1836, 2013. doi:10.1001/jama.2013.280386.
234. Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Gennaz-zani A, Buralli S, Taddei S, Salvetti A. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation 101: 2258-2263, 2000. doi:10.1161/01.CIR.101.19.2258.
235. Vitale C, Mercuro G, Cerquetani E, Marazzi G, Patrizi R, Pelliccia F, Volterrani M, Fini M, Collins P, Rosano GM. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 28: 348-352, 2008. doi:10. 1161/ATVBAHA.107.158634.
236. Wang H, Chen H. Gender difference in the response to valsartan/ amlodipine single-pill combination in essential hypertension (China Status II): An observational study. J Renin Angiotensin Aldosterone Syst 17: 1470320316643903, 2016. doi:10.1177/1470320316643903.
237. Wang H, Jessup JA, Zhao Z, Da Silva J, Lin M, MacNamara LM, Ahmad S, Chappell MC, Ferrario CM, Groban L. Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats. PLoS One 8: e76992, 2013. doi:10.1371/journal.pone.0076992.
238. Wang Y, Shoemaker R, Powell D, Su W, Thatcher S, Cassis L. Differential effects of Mas receptor deficiency on cardiac function and blood pressure in obese male and female mice. Am J Physiol Heart Circ Physiol 312: H459-H468, 2017. doi:10.1152/ajpheart.00498.2016.
239. Webb CM, Ghatei MA, McNeill JG, Collins P. 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation 102: 1617-1622, 2000. doi:10.1161/01.CIR.102.14.1617.
240. Weber MA, Black H, Bakris G, Krum H, Linas S, Weiss R, Linse-man JV, Wiens BL, Warren MS, Lindholm LH. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet 374: 1423-1431, 2009. doi:10.1016/S0140-6736(09)61500-2.
241. B receptor contribution to vascular dysfunction in postmenopausal women. Am J Physiol Regul Integr Comp Physiol 313: R51-R57, 2017. doi:10.1152/ajpregu.00410.2016.
242. Wenner MM, Taylor HS, Stachenfeld NS. Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome. J Physiol 589: 4671-4679, 2011. doi:10.1113/jphysiol.2011.216218.
243. Wenner MM, Taylor HS, Stachenfeld NS. Androgens influence microvascular dilation in PCOS through ET-A and ET-B receptors. Am J Physiol Endocrinol Metab 305: E818-E825, 2013. doi:10.1152/ajpendo. 00343.2013.
244. Wenner MM, Taylor HS, Stachenfeld NS. Progesterone enhances adrenergic control of skin blood flow in women with high but not low orthostatic tolerance. J Physiol 589: 975-986, 2011. doi:10.1113/jphysiol.2010.194563.
245. Westby CM, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men. Clin Sci (Lond) 120: 485-491, 2011. doi:10.1042/CS20100475.
246. Wilcox JG, Hatch IE, Gentzschein E, Stanczyk FZ, Lobo RA. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors. Fertil Steril 67: 273-277, 1997. doi:10.1016/S0015-0282(97)81910-3.
247. Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W, Bartholomew M. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 54: 255-259, 1990. doi:10.1016/S0015-0282(16)53699-1.
248. Wilhelmson AS, Fagman JB, Johansson I, Zou ZV, Andersson AG, Svedlund Eriksson E, Johansson ME, Lindahl P, Fogelstrand P, Tivesten Å. Increased intimal hyperplasia after vascular injury in male androgen receptor-deficient mice. Endocrinology 157: 3915-3923, 2016. doi:10.1210/en.2016-1100.
249. Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Evidence that parenteral testosterone therapy may improve endothelium-dependent and-independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 86: 158-161, 2001. doi:10.1210/jcem.86.1.7103.
250. Wu CC, Cheng J, Zhang FF, Gotlinger KH, Kelkar M, Zhang Y, Jat JL, Falck JR, Schwartzman ML. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase. Hypertension 57: 788-794, 2011. doi:10.1161/HYPERTENSIONAHA.110.161570.
251. Xue B, Beltz TG, Guo F, Johnson AK. Sex differences in maternal gestational hypertension-induced sensitization of angiotensin II hypertension in rat offspring: the protective effect of estrogen. Am J Physiol Regul Integr Comp Physiol 314: R274-R281, 2018. doi:10.1152/ajpregu.00216.2017.
252. Yuan W, Cheng G, Li B, Li Y, Lu S, Liu D, Xiao J, Zhao Z. Endothelin-receptor antagonist can reduce blood pressure in patients with hypertension: a meta-analysis. Blood Press 26: 139-149, 2017. doi:10. 1080/08037051.2016.1208730.
253. Zerr-Fouineau M, Jourdain M, Boesch C, Hecker M, Bronner C, Schini-Kerth VB. Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells. Arterioscler Thromb Vasc Biol 29: 586-593, 2009. doi:10.1161/ATVBAHA.108.178004.
254. Zhang Y, Davidge ST. Effect of estrogen replacement on vasoconstrictor responses in rat mesenteric arteries. Hypertension 34: 1117-1122, 1999. doi:10.1161/01.HYP.34.5.1117.
255. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295: 505-508, 2002. doi:10.1126/science.1065250.